These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 11384807

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA, Mansour RT, Serour GI, El Helw BA, Shaarawy M.
    Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
    [Abstract] [Full Text] [Related]

  • 4. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
    Liang W, Chen S, Xing F.
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program.
    Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogio G, Genazzani AR.
    Fertil Steril; 1998 Sep; 70(3):560-4. PubMed ID: 9757891
    [Abstract] [Full Text] [Related]

  • 9. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
    Wang TH, Horng SG, Chang CL, Wu HM, Tsai YJ, Wang HS, Soong YK.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome.
    D'Ambrogio G, Fasciani A, Monti M, Cattani R, Genazzani AR, Artini PG.
    Gynecol Endocrinol; 1999 Oct; 13(5):311-5. PubMed ID: 10599547
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
    Abramov Y, Barak V, Nisman B, Schenker JG.
    Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated interleukin-10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome.
    Manolopoulos K, Lang U, Gips H, Braems GA.
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec 01; 99(2):226-31. PubMed ID: 11788177
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
    Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J, Simón C.
    Fertil Steril; 1999 Mar 01; 71(3):482-9. PubMed ID: 10065786
    [Abstract] [Full Text] [Related]

  • 19. [Preliminary study on the role of vascular endothelial growth factor in pathogenesis of ovarian hyperstimulation syndrome].
    Zhou C, Yu C, Zhuang G.
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov 01; 36(11):654-6. PubMed ID: 11930688
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.